Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Filings indexed 809 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country IT Italy
Listing XMIL DIA

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Informativa sul programma di acquisto di azioni proprie di Diasorin S.p.A. - Periodo 27/4/2026 – 30/4/2026
Regulatory Filings
2026-04-30 English
Shareholders' Meeting April 29, 2026 - Summary report on votes
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document records detailed voting tallies and percentages for items voted at the Diasorin ordinary meeting on 29 April 2026, including approval of financial statements, profit allocation, remuneration policy, and a stock option plan. This is a formal declaration of shareholder voting results, matching the Definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-29 English
Assemblea degli Azionisti del 29 aprile 2026 - Rendiconto sintetico delle votazioni
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document provides detailed vote counts and percentages on specific agenda items from the ordinary shareholders’ meeting (Assemblea ordinaria) of Diasorin S.p.A. held on 29 April 2026, indicating the outcomes of shareholder votes. It is not the meeting materials, report attachments, or a financial statement, but the official voting results. Therefore, it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-29 Italian
Report on the treasury shares buy-back plan of Diasorin S.p.A. – Period 20/04/2026 - 24/04/2026
Transaction in Own Shares Classification · 96% confidence The document is a press release from Diasorin titled “Report on the treasury shares buy-back plan” covering specific purchase quantities, dates, and transaction details. It discloses actual share repurchases by the company (treasury shares acquired) rather than simply announcing a future plan or publishing a linked report. This matches the definition of a “Transaction in Own Shares” (share buy-back) category.
2026-04-24 English
Informativa sul programma di acquisto di azioni proprie di Diasorin S.p.A. - Periodo 20/4/2026 – 24/4/2026
Transaction in Own Shares Classification · 92% confidence The document is a regulatory press release from Diasorin S.p.A. providing detailed weekly information on its authorized share repurchase program, including aggregated and transaction‐level data for shares bought back between 20/4/2026 and 24/4/2026. It explicitly reports the purchase of its own shares under an AGM‐approved buyback authorization. This clearly falls under “Transaction in Own Shares” rather than a capital increase or other corporate action.
2026-04-24 English
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is a press release by Diasorin communicating the total amount of voting rights and share capital breakdown as of the record date, pursuant to Consob Regulation. It is not an earnings release or full report, but an announcement specifically about voting rights totals. This corresponds to the category ‘Declaration of Voting Results & Voting Rights Announcements’ (DVA).
2026-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.